SGA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SGA is not a good buy right now. With no proprietary buy signals, deteriorating latest-quarter fundamentals (revenue down, margins sharply down, and a loss), and heavy insider selling, the risk/reward is unattractive for an impatient investor seeking immediate upside. I would avoid buying here (and would trim/exit if already holding).
Price/levels: SGA is trading at 11.36, sitting just above the pivot (11.315) and near first resistance (R1 11.494) with support at 11.136. Trend/momentum: MACD histogram is positive (0.0434) and expanding, which is mildly bullish near-term. RSI(6) at ~61.6 is neutral-to-slightly bullish, not overbought. Structure: Converging moving averages suggest consolidation rather than a strong trend. Implication: While momentum is slightly positive, upside is likely capped quickly by nearby resistance (11.49–11.60) and the broader setup looks range-bound.
Intellectia Proprietary Trading Signals
MACD momentum is improving (positive and expanding), suggesting some near-term bid.
Hedge funds are neutral with no significant recent trend, implying no strong institutional selling pressure from that cohort.
Insiders are Selling! Selling amount increased 610.55% over the last month, a major negative sentiment signal.
No news in the past week, meaning no obvious near-term catalyst to re-rate the stock upward.
Pattern-based forward trend is slightly negative: estimated 60% chance of -0.05% next day, -0.13% next week, -0.52% next month.
Nearby resistance at ~11.49–11.60 may limit upside quickly for an impatient entry.
Latest reported quarter: 2025/Q3. Revenue: 28.166M, down -1.84% YoY (mild contraction). Net income: -0.504M, down -141.04% YoY (swung deeper into loss). EPS: -0.08, down -140.00% YoY. Gross margin: 7.76, down -51.53% YoY (sharp margin compression). Bottom line: Growth and profitability trends deteriorated meaningfully in the latest quarter, which undermines the bull case.
No analyst rating or price target change data was provided, so there is no observable recent Wall Street upgrade/downgrade trend to support a buy thesis. From the data available, the 'pro' view would lean on modest technical momentum; the 'con' view is dominated by weakening financials and significant insider selling.
